Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edouard Louis

Showing results (1-10 of 290) with videos related to

Pageof 29
Sort By:
Current Opinion in Gastroenterology|June 4, 2015
When it is not inflammatory bowel disease: differential diagnosisEdouard Louis
Inflammatory Intestinal Diseases|February 28, 2022
Stopping Anti-TNF in Crohn's Disease Remitters: Pros and Cons: The ProsEdouard Louis
Frontiers in Medicine|January 24, 2020
Tailoring Biologic or Immunomodulator Treatment Withdrawal in Inflammatory Bowel DiseaseEdouard Louis
Inflammatory Bowel Diseases|March 17, 2018
Stopping Biologics in IBD-What Is the Evidence?Edouard Louis
Digestive Diseases (Basel, Switzerland)|September 14, 2013
Strategic use of immunosuppressants and anti-TNF in inflammatory bowel diseaseEdouard Louis
Journal of Crohn'S & Colitis|November 3, 2018
Do We Still Need Predictors of Disease Severity When Applying a Treat-to-Target Approach in Inflammatory Bowel Disease?Edouard Louis
Digestive Diseases (Basel, Switzerland)|July 17, 2012
Epidemiology of the transition from early to late Crohn's diseaseEdouard Louis
The Lancet. Gastroenterology & Hepatology|April 8, 2023
Treatment de-escalation in Crohn's disease - Author's replyEdouard Louis
Gastroenterology & Hepatology|March 21, 2025
Use of Interleukin-23 Inhibitors for the Treatment of Inflammatory Bowel DiseaseEdouard Louis
Journal of Crohn'S & Colitis|December 24, 2014
Fecal calprotectin: towards a standardized use for inflammatory bowel disease management in routine practiceEdouard Louis
Pageof 29

Showing results (1-10 of 290) with videos related to

Sort By:
Pageof 29
Current Opinion in Gastroenterology|June 4, 2015
When it is not inflammatory bowel disease: differential diagnosisEdouard Louis
Inflammatory Intestinal Diseases|February 28, 2022
Stopping Anti-TNF in Crohn's Disease Remitters: Pros and Cons: The ProsEdouard Louis
Frontiers in Medicine|January 24, 2020
Tailoring Biologic or Immunomodulator Treatment Withdrawal in Inflammatory Bowel DiseaseEdouard Louis
Inflammatory Bowel Diseases|March 17, 2018
Stopping Biologics in IBD-What Is the Evidence?Edouard Louis
Digestive Diseases (Basel, Switzerland)|September 14, 2013
Strategic use of immunosuppressants and anti-TNF in inflammatory bowel diseaseEdouard Louis
Journal of Crohn'S & Colitis|November 3, 2018
Do We Still Need Predictors of Disease Severity When Applying a Treat-to-Target Approach in Inflammatory Bowel Disease?Edouard Louis
Digestive Diseases (Basel, Switzerland)|July 17, 2012
Epidemiology of the transition from early to late Crohn's diseaseEdouard Louis
The Lancet. Gastroenterology & Hepatology|April 8, 2023
Treatment de-escalation in Crohn's disease - Author's replyEdouard Louis
Gastroenterology & Hepatology|March 21, 2025
Use of Interleukin-23 Inhibitors for the Treatment of Inflammatory Bowel DiseaseEdouard Louis
Journal of Crohn'S & Colitis|December 24, 2014
Fecal calprotectin: towards a standardized use for inflammatory bowel disease management in routine practiceEdouard Louis
Pageof 29